Cisplatin sensitivity in cAMP-dependent protein kinase mutants of Saccharomyces cerevisiae

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3187-3192

  Cvijic, M E ^a   Yang, W L ^a   Chin, K V ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

BCY1; cAMP dependent protein kinase; Cisplatin; Drug resistance; TPK

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ADRENAL CORTEX CARCINOMA; ARTICLE; CHO CELL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG EFFICACY; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE MUTATION; MUTANT; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

ANTINEOPLASTIC AGENTS; CISPLATIN; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG RESISTANCE; GENE DELETION; PROTEIN-TYROSINE KINASES; SACCHAROMYCES CEREVISIAE;

EID: 0031788778     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hartwell LH, Szankasi P, Roberts CJ, Murray AW and Friend S: Integrating genetic approaches into the discovery of anticancer drugs. Science 278: 1064-1068, 1992.
2. Balzi E and Goffeau A: Multiple pleiotropic drug resistance in yeast. Biochim Biophys Acta 1073: 241-252, 1991.
3. Balzi E and Goffeau A: Genetics and biochemistry of yeast multidrug resistance. Biochim Biophys Acta 1187: 152-162, 1994.
4. Balzi E and Goffeau A: PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Bioenergetics and Biomembranes 27: 71-76, 1995.
5. Balzi E, Chen W, Ulaszewski S, Capieaux E and Goffeau A: The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J Biol Chem 262: 16871-16879, 1987.
6. Moye-Rowley WS, Harshman KD and Parker CS: Yeast YAP1 encodes a novel form of the jun family of transcriptional activator proteins. Genes Dev 3: 283-292, 1989.
7. Bossier P, Ferrandes L, Rocha D and Rodriguez-Pousada C: Overexpression of YAP2, coding for a new YAP protein, and YAP1 in Saccharomyces cerevisiae alleviates growth inhibition caused by 1, 10-phenanthioline. J Biol Chem 268: 23640-23645, 1993.
8. Delaveau T, Delahodde A, Carvajal E, Subik J and Jacq C: PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol Gen Genet 244: 501-51 1, 1994.
9. Dexter D, Moye-Rowley WS, Wu AL and Golin J: Mutations in the yeast PDR3, PDR4, PDR7 and PDR9 pleiotropic (multiple) drug resistance loci affect the transcript level of an ATP binding cassette transporter encoding gene, PDR5. Genetics 136: 505-515, 1994.
10. McGrath JP and Varshavsky A: The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 340: 400-404, 1989.
11. Kuchler K, Goransson M, Visnawathan M and Thorner J: Dedicated transporters for peptide export and intercompartmental traffic in yeast. CSH Symp Quant Biol 57: 579-592, 1992.
12. Kuchler K and Thorner J: Functional expression of human mdr1 in the yeast Saccharomyces cerevisiae. Proc Natl Acad Sci 89: 2302-2306, 1992.
13. Raymond M, Gros PG, Whiteway M and Thomas DY: Functional complementation of yeast ste6 by a mammalian multidrug resistance mdr gene. Science 10: 232-234, 1992.
14. Raymond M, Ruetz S, Thomas DY and Gros P: Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520. Mol Cell Biol 14: 277-286, 1994.
15. Servos J, Hoase E and Brendel M: Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-N-oxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol Gen Genet 236: 214-218, 1993.
16. Balzi E, Wang M, Leterme S, Van Dyck L and Goffeau A: PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J Biol Chem 269: 2206-2214, 1994.
17. Szczypka MS, Wemmie JA, Moye-Rowley WS and Thiele DJ: A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. J Biol Chem 269: 22853-22857, 1994.
18. Wemmie JA, Wu AL, Harshman KD, Parker CS and Moye-Rowley WS: Transcriptional activation mediated by the yeast AP-1 protein is required for normal cadmium tolerance. J Biol Chem 268: 14690-14697, 1994.
19. Katzmann DJ, Hallstrom TC, Voet M, Wysock W, Golin J, Volckaert G and Moye-Rowley WS: Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae. Mol Cell Biol 15: 6875-6883, 1995.
20. Mahe Y, Parle-McDermott A, Nourani A, Delahodde A, Lamprecht A and Kuckler, K: The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Molecular Microbiology 20: 109-117, 1996.
21. Huang JC, Zamble DB, Reardon JT, Lippard SJ and Sancar A: HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc Natl Acad USA 91: 10394-10398, 1994.
22. Donahue BA, Augot M, Bellon SF, Treiber DK, Toney JH, Lippard SJ and Essigman JM: Characterization of a DNA damage recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) abd D(ApG) DNA adducts on the anticancer drug cisplatin. Biochemistry 29: 5872-5880, 1990.
23. Brown SJ, Kellett PJ and Lippard SJ: Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 26: 603-605, 1993.
24. McA'Nulty MM, Whitehead JP and Lippard SJ: Binding of IXR1, a yeast HMG-domain protein, to cispaltin-DNA adducts in vitro and in vivo. Biochemistry 35: 6089-6099, 1994.
25. McA'Nulty MM and Lippard SJ: The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutation Research 362: 75-86, 1996.
26. Jones JC, Zhen W, Reed E, Parker RJ, Sancar A and Bohr VA: Gene specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J Biol Chem 266: 7101-7107, 1991.
27. Zhen W, Link CJ, O'Connor PM, Read E, Parker R, Howell SB and Bohr VA: Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol 12: 3689-3698, 1992.
28. Chu G and Chang E: Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. Proc Natl Acad Sci USA 87: 3324-3327, 1990.
29. Zamble DB and Lippard SJ: Cisplatin and DNA repair in cancer chemotherapy. Trends in Biochem Sci 20: 435-439, 1995.
30. Hannan MA, Zimmer SG and Hazle J: Mechanisms of cisplatin (cis-diamminodichloroplatinum II)-induced cytotoxicity and genotoxicity in yeast. Mutation Research 127: 23-30, 1984.
31. Wang Z, Wu X and Freidberg EC: Nucleotide-excision repair of DNA in cell-free extracts of the yeast Saccharomyces cerevisae. Proc Natl Acad Sci USA 9: 4907-4911, 1994.
32. Abe H, Morimasa W, Kimitoshi K and Kuwano M: Altered drug sensitivities to anticancer agents in radiation-sensitive DNA repair deficient yeast mutants. Anticancer Research 17: 1807-1810, 1994.
33. Liu B, Cvijic ME, Jetzt A and Chin K-V: Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants. Cell Growth Differ 7: 1105-1112, 1996.
34. Cvijic ME and Chin KV: Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin. Int J Cancer 72: 345-350, 1997.
35. Cvijic ME, Yang W-L and Chin K-V: Cisplatin resistance in cAMP-dependent protein kinase mutants. Pharmacol Therap 78: 115-128, 1998.
36. Fedor-Chaiken M, Deschenes RJ and Broach JR: SRV2, a gene required for RAS activation of adenylate cyclase in yeast. Cell 61: 329-340, 1990.
37. 2+ influx into the golgi. Mol Gen Genet 251: 556-564, 1996.
38. Zaremberg V and Moreno S: Analysis of the mechanism of activation of cAMP- dependent protein kinase through the study of mutants of the yeast regulatory subunit. Eur J Biochem 237: 136-142, 1996.
39. Ito H, Fukuda Y, Murata K, and Kimura A: Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153: 163-168, 1983.
40. Kataoka T, Powers S, McGill C, Fasano O, Strathern J, Broach J and Wigler M: Genetic analysis of yeast RAS 1 and RAS2 genes. Cell 37: 437-445, 1984.
41. Toda T, Uno I, Ishikawa T, Powers S, Kataoka T, Broek D, Cameron S, Broach J, Matsumato K and Wigler M: In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell 40: 27-36, 1985.
42. Abraham I, Chin K-V, Gottesman MM, Mayo J and Sampson KE: Transfection of a mutant regulatory subunit gene of cAMP-dependent protein kinase causes increased drug sensitivity and decreased expression of P-glycoprotein. Exp Cell Res 189: 133-141, 1990.
43. Francis SH and Corbin JD: Structure and function of cyclic nucleotide-dependent protein kinases. Annu RevPhysiol 56: 237-72, 1994.
44. Matsumato K, Uno I and Ishikawa T: Genetic analysis of the role of cAMP in yeast. Yeast 1: 15-24, 1985.
45. Cannon JF and Tatchell K: Characterization of Saccharomyces cerevisiae genes encoding subunits of cyclic AMP-dependent protein kinase. Mol Cell Biol 7: 2653-2663, 1987.
46. Toda T, Cameron S, Sass P, Zoller M, Scott JD, McMullen B, Hurwitz M, Krebs EG and Wigler M: Cloning and Characterization of BCY1, a locus encoding a regulatory subunit of the cyclic AMP-dependent protein kinase in Saccharomyces cerevisiae. Mol Cell Biol 7: 1371-1377, 1987.
47. Toda T, Cameron S, Sass P, Zoller M and Wigler M: Three different genes in S. cerevisiae encode the catalytic subunits of the cAMP-dependent protein kinase. Cell 50: 277-287, 1987
48. Broach J: RAS genes in Saccharomyces cerevisiae: signal transduction in search of a pathway. Trends in Genetics 7: 28-33, 1991.
49. Abraham I, Hunter RJ, Sampson KE, Smith S, Gottesman MM and Mayo JK: Cyclic AMP-dependent protein kinase regulates sensitivity of cells to multiple drugs. Mol Cell Biol 7: 3098-3106, 1987.
50. Chin K-V, Chauhan SS, Abraham I, Sampson KE, Krolczyk AJ, Wong M, Schimmer B, Pastan I and Gottesman MM: Reduced expression of the multidrug-resistant gene in cAMP-dependent protein kinase mutant cell lines. J Cell Physiol 152: 87-94, 1992.
51. Cvijic ME and Chin K-V: Regulation of P-glycoprotein expression in cAMP-dependent protein kinase mutants. Cell Growth Differ 8: 1243-1247, 1997.